5 Am Venture Management, LLC Crinetics Pharmaceuticals, Inc. Transaction History

5 Am Venture Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.97 - $30.59 $6.39 Million - $12.2 Million	-400,000 Reduced 46.39%	462,286 $13.7 Million
Q4 2021 Feb 03, 2022	SELL	$19.35 - $28.41 $9.68 Million - $14.2 Million	-500,000 Reduced 36.7%	862,286 $24.5 Million
Q2 2020 Aug 05, 2020	SELL	$13.04 - $23.23 $6.52 Million - $11.6 Million	-500,000 Reduced 26.85%	1,362,286 $23.9 Million
Q1 2020 Apr 29, 2020	SELL	$11.52 - $26.46 $5.76 Million - $13.2 Million	-500,000 Reduced 21.17%	1,862,286 $27.4 Million
Q4 2019 Feb 05, 2020	BUY	$15.24 - $25.09 $36 Million - $59.3 Million	2,362,286 New	2,362,286 $59.3 Million

242

80.1M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.01B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 5 Am Venture Management, LLC with notifications on news.